home / stock / apto / apto quote
Last: | $1.25 |
---|---|
Change Percent: | -1.57% |
Open: | $1.24 |
Close: | $1.27 |
High: | $1.285 |
Low: | $1.24 |
Volume: | 9,823 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.25 | $1.24 | $1.27 | $1.285 | $1.24 | 9,823 | 04-19-2024 |
$1.27 | $1.25 | $1.27 | $1.29 | $1.25 | 34,123 | 04-18-2024 |
$1.26 | $1.27 | $1.26 | $1.34 | $1.2582 | 31,324 | 04-17-2024 |
$1.27 | $1.29 | $1.27 | $1.32 | $1.2 | 45,647 | 04-16-2024 |
$1.3 | $1.39 | $1.3 | $1.4 | $1.29 | 65,087 | 04-15-2024 |
$1.36 | $1.39 | $1.36 | $1.4397 | $1.34 | 35,185 | 04-12-2024 |
$1.38 | $1.4 | $1.38 | $1.43 | $1.37 | 51,284 | 04-11-2024 |
$1.38 | $1.39 | $1.38 | $1.4758 | $1.38 | 54,000 | 04-10-2024 |
$1.41 | $1.48 | $1.41 | $1.49 | $1.4 | 179,377 | 04-09-2024 |
$1.47 | $1.45 | $1.47 | $1.52 | $1.38 | 113,186 | 04-08-2024 |
$1.38 | $1.41 | $1.38 | $1.4699 | $1.38 | 56,092 | 04-05-2024 |
$1.43 | $1.47 | $1.43 | $1.56 | $1.39 | 134,594 | 04-04-2024 |
$1.44 | $1.57 | $1.44 | $1.58 | $1.44 | 113,290 | 04-03-2024 |
$1.58 | $1.65 | $1.58 | $1.67 | $1.51 | 102,707 | 04-02-2024 |
$1.6 | $1.72 | $1.6 | $1.7203 | $1.53 | 122,551 | 04-01-2024 |
$1.66 | $1.5 | $1.66 | $1.7 | $1.5 | 137,093 | 03-29-2024 |
$1.66 | $1.5 | $1.66 | $1.7 | $1.5 | 137,093 | 03-28-2024 |
$1.5 | $1.5 | $1.5 | $1.54 | $1.46 | 79,010 | 03-27-2024 |
$1.6 | $1.54 | $1.6 | $1.6 | $1.48 | 57,884 | 03-26-2024 |
$1.51 | $1.61 | $1.51 | $1.61 | $1.49 | 53,492 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aptose Biosciences Inc. Company Name:
APTO Stock Symbol:
NASDAQ Market:
Aptose Biosciences Inc. Website:
Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with Excellent Safety Profile Luxeptinib G3 Formulation Achieves Desired Levels and Positions for Future Trials Conference Call ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
SAN DIEGO and TORONTO, March 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO, TSX:APS), a clinical- stage precision oncology c...